243

+1.57%↑

BAS

46.85

+2.38%↑

324.2

-1.04%↓

REP

22.67

-6.75%↓

EXE.US

107.66

+0.36%↑

243

+1.57%↑

BAS

46.85

+2.38%↑

324.2

-1.04%↓

REP

22.67

-6.75%↓

EXE.US

107.66

+0.36%↑

243

+1.57%↑

BAS

46.85

+2.38%↑

324.2

-1.04%↓

REP

22.67

-6.75%↓

EXE.US

107.66

+0.36%↑

243

+1.57%↑

BAS

46.85

+2.38%↑

324.2

-1.04%↓

REP

22.67

-6.75%↓

EXE.US

107.66

+0.36%↑

243

+1.57%↑

BAS

46.85

+2.38%↑

324.2

-1.04%↓

REP

22.67

-6.75%↓

EXE.US

107.66

+0.36%↑

Home・Aandelen Lijst・Viridien

V
Viridien

Gesloten

SectorEnergie

129.1 1.49

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

123.4

Max

129.8

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+28.5% upside

Dividenden
By Dow Jones
Volgende Winsten	5 mei 2026

Nieuwssentiment

By Acuity

43%

57%

48 / 137 Rangschikking in Energy

Viridien Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 mrt 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mrt 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mrt 2026, 21:51 UTC

Acquisities, Fusies, Overnames

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mrt 2026, 23:59 UTC

Marktinformatie

Global Equities Roundup: Market Talk

23 mrt 2026, 23:59 UTC

Marktinformatie

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mrt 2026, 23:50 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mrt 2026, 23:37 UTC

Marktinformatie

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Equities Roundup: Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mrt 2026, 22:40 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mrt 2026, 22:23 UTC

Marktinformatie

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mrt 2026, 22:22 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mrt 2026, 22:18 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mrt 2026, 22:15 UTC

Acquisities, Fusies, Overnames

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mrt 2026, 22:08 UTC

Marktinformatie

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mrt 2026, 21:10 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mrt 2026, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie

Winsten

Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Viridien Prognose

Koersdoel

By TipRanks

28.5% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 165 EUR 28.5%

Hoogste 180 EUR

Laagste 150 EUR

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Viridien - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Viridien - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

48 / 137 Rangschikking in Energie

Financieel

Andere aandelen uit de sector

Schneider Electric SE

243

↑ +1.57%

BAS

BASF SE

46.85

↑ +2.38%

Dassault Aviation SA.

324.2

↓-1.04%

REP

Repsol SA

22.67

↓-6.75%

EXE.US

Expand Energy Corp

107.66

↑ +0.36%

V Viridien

Overzicht

Wijziging aandelenprijs

Aanbevelingen

Dividenden

Nieuwssentiment

Viridien Grafiek

Gerelateerd nieuws

Peer Vergelijking

Viridien Prognose

Koersdoel

Beoordelingsconsensus

Sentiment

Financieel

Andere aandelen uit de sector

V
Viridien